Patent reform saga opens in Senate
Work on patent reform legislation begins in the Senate June 6 with hearings by the full Judiciary Committee. Although crafted by a bipartisan group of leaders from the House and Senate Judiciary Committees, the bill remains a work in progress (1"The Pink Sheet" April 23, 2007, p. 8). Provisions limiting damage awards for patent infringement and lengthening the time frame for patent challenges remain open issues. A procedural maneuver kept the original bill intact when it moved out of the Courts, Internet and Intellectual Property Subcommittee in May, and subcommittee chairman Rep. Howard Berman, D-Calif., has pledged to reach a compromise to facilitate passage of the legislation this year (2"The Pink Sheet" May 21, 2007, p. 13)...
You may also be interested in...
Rep. Howard Berman, D-Calif., has moved patent reform legislation to the House Judiciary Committee but has not yet hammered out a compromise on the measure's damage provisions
A new patent reform bill introduced in Congress is likely to undergo revisions in the face of criticism from the pharmaceutical industry
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.